Pharmaceutical IP and competition law in the EU: overview | Practical Law

Pharmaceutical IP and competition law in the EU: overview | Practical Law

A Q&A guide to medicinal product regulation and product liability law in the EU.

Pharmaceutical IP and competition law in the EU: overview

Practical Law Country Q&A 9-617-0567 (Approx. 32 pages)

Pharmaceutical IP and competition law in the EU: overview

by Alexis Fierens, Raf Schoefs, Emma Stockman, Simon Verschaeve and Astrid Dorigny-Sicard, DLA Piper UK LLP
Law stated as at 01 Mar 2021European Union
A Q&A guide to medicinal product regulation and product liability law in the EU.
The Q&A gives a high-level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Medicinal product regulation and product liability in the EU: overview.